dc.contributor.author | Akyol L. | |
dc.contributor.author | Aslan K. | |
dc.contributor.author | Özgen M. | |
dc.contributor.author | Sayarlioglu M. | |
dc.date.accessioned | 2020-06-21T09:42:52Z | |
dc.date.available | 2020-06-21T09:42:52Z | |
dc.date.issued | 2015 | |
dc.identifier.issn | 1757-790X | |
dc.identifier.uri | https://doi.org/10.1136/bcr-2015-211439 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12712/5206 | |
dc.description | PubMed: 26578505 | en_US |
dc.description.abstract | We present a case of a neurosarcoidosis patient with skin lesions. A 50-year-old woman was admitted with a 1-year history of violaceous, smooth and shiny plaques on her face and right arm. These lesions were biopsied and the histological examination indicated sarcoidosis. The patient had a history of headache and syncope that lasted for about 1 h. Brain CT showed masses measuring 37×20 mm in both frontal lobes. Thoracic and abdominal CT showed many pathologically enlarged lymph nodes. The patient was diagnosed with cutaneous, lung and neuronal sarcoidosis, and treated with 20 mg/day methylprednisolone, 15 mg/week methotrexate, 10 mg/week folic acid, 400 mg/day hydroxychloroquine and 800 mg/day carbamazepine. One month later, the patient's neurological symptoms had improved and her skin lesions had decreased. At 6-month follow-up, the size of the cranial masses had markedly regressed. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | BMJ Publishing Group | en_US |
dc.relation.isversionof | 10.1136/bcr-2015-211439 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | A rare comorbidity: Neurosarcoidosis and cutaneous sarcoidosis | en_US |
dc.type | article | en_US |
dc.contributor.department | OMÜ | en_US |
dc.identifier.volume | 2015 | en_US |
dc.relation.journal | BMJ Case Reports | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |